Perspective Therapeutics, Inc. (CATX): Shareholders' Equity
$207.03M
As of 2025-12-31
$323.86M
As of 2026-06-30
+55.9%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $207.03M | -28.8% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $290.67M | +286.6% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $75.18M | +37.6% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $54.64M | n/a | 2024-03-28, Balance as of period end |
| 2022-06-30 | $61.28M | -9.1% | 2024-03-28, Balance as of period end |
| 2021-06-30 | $67.41M | n/m | 2022-09-28, Balance as of period end |
| 2020-06-30 | $5.72M | -25.5% | 2022-09-28, Balance as of period end |
| 2019-06-30 | $7.68M | +52.7% | 2021-09-27, Balance as of period end |
| 2018-06-30 | $5.03M | -52.6% | 2020-09-25, Balance as of period end |
| 2017-06-30 | $10.60M | -35.4% | 2019-09-27, Balance as of period end |
| 2016-06-30 | $16.40M | -21.1% | 2018-09-26, Balance as of period end |
| 2015-06-30 | $20.78M | -13.2% | 2017-09-28, Balance as of period end |
| 2014-06-30 | $23.96M | +346.4% | 2016-09-09, Balance as of period end |
| 2013-06-30 | $5.37M | -7.8% | 2015-09-14, Balance as of period end |
| 2012-06-30 | $5.82M | -9.8% | 2013-09-30, Balance as of period end |
| 2011-06-30 | $6.45M | n/a | 2012-10-26, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | 2025-12-31 | $207.03M | -28.8% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $213.99M | -11.2% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $161.55M | +0.3% |
| Damora Therapeutics, Inc. (DMRA) | 2025-12-31 | $240.38M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$438.17M | n/m |
| Contineum Therapeutics, Inc. (CTNM) | 2025-12-31 | $260.99M | +31.8% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $206.75M | +519.8% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $245.15M | +75.7% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $55.59M | -52.1% |
Compare CATX, ARCT, NATR, DMRA side by side · Screen every company in Pharmaceutical Preparations ↗